Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
  • Peer groups
    • HR Peer Group
    • Recruitment Peer Group
    • Marketing Peer Group
    • PA Peer Group
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job
    • Peer groups
      • HR Peer Group
      • Recruitment Peer Group
      • Marketing Peer Group
      • PA Peer Group

    Breadcrumb

    1. Home
    2. News
    3. Search results
    Displaying results 26 - 50 of 673 Clear search
    Zyme Communications
    ‘Lab-in-the-loop’ workflow
    Healthcare and Life Science 12 Oct 2026

    Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR

    New paper published in Nature shows watermarks can be embedded in AI-generated proteins without compromising function, confirmed with binding kinetics data from Carterra’s LSA-XT

    Zyme Communications
    Dr Louise Modis, Chief Executive Officer, Amphista	Dr Eytan Stein, Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center
    Healthcare and Life Science 12 Oct 2026

    Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

    AMX-883, Amphista’s first asset to enter the clinic, is a potent, selective, orally bioavailable DCAF16-mediated BRD9 degrader targeting acute myeloid leukemia (AML) The first-in-human ‘BRAMLIE’ (BR(D9) AML Interventional Evaluation) trial will assess the safety, p
    Zyme Communications
    Carterra logo
    Healthcare and Life Science 07 Oct 2026

    Carterra advances lab-in-the-loop drug discovery through new scientific collaboration

    Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery

    Zyme Communications
    Prashant Shah, Co-founder, o2h Group
    Healthcare and Life Science 05 Oct 2026

    Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027

    · o2h co-discovery to host second edition of the Cambridge x London Life Sciences Showcase, taking place on 13 January 2027 at 111 Minna Gallery, San Francisco 

    Zyme Communications
    Dr Brendan Swain, CSO and Founder, Shift Bioscience
    Healthcare and Life Science 05 Oct 2026

    Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

    · Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models

    Zyme Communications
    logo
    Healthcare and Life Science 01 Oct 2026

    CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

    Four sessions across twodays focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including Novo
    Zyme Communications
    David Venables, CEO of Laverock Therapeutics
    Healthcare and Life Science 30 Sep 2026

    Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine

    Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety

    Zyme Communications
    Dr Ian Jepson, Non-Executive Director, Cytotrait	Dr Tim Brears, Executive Chair, Cytotrait
    Healthcare and Life Science 29 Sep 2026

    Cytotrait appoints Dr Ian Jepson as Non-Executive Director

    Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologiesFollows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform and establish trait enhancem
    Zyme Communications
    Eppendorf SpinPro 8 R
    Healthcare and Life Science 23 Sep 2026

    Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge

    Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the expansion of its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, f

    Zyme Communications
    Novai logo
    Healthcare and Life Science 23 Sep 2026

    Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy

    Novai.

    Zyme Communications
    logo
    Healthcare and Life Science 17 Sep 2026

    Big Picture Bio founded to identify, design and optimise promising cancer combination therapies

    New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostI
    Zyme Communications
    Flip™ product platform
    Healthcare and Life Science 15 Sep 2026

    Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform

    Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applicationsInvestment led by The FSE Group alongside existi
    Zyme Communications
    Nicolas Koebel, Chief Executive Officer of EpilepsyGTx	Jimmy Vanhove, Chief Executive Officer of Viralgen
    Healthcare and Life Science 09 Sep 2026

    EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial

    Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people

    Zyme Communications
    Eppendorf Centrifuge 5811 R
    Healthcare and Life Science 08 Sep 2026

    Eppendorf launches new refrigerated Centrifuge 5811 R

    Hamburg, Germany, 8 September, 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the launch of the Centrifuge 5811

    Zyme Communications
    Dr Julian Gough, CEO and Founder, OutSee	Dan Bolser, Principal Bioinformatician, OutSee
    Healthcare and Life Science 08 Sep 2026

    OutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation

    Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, NomalyFunding provided jointly by Innovate UK and Empirical Ventures through Innovate UK Growth Catalyst – Investor Partn
    Zyme Communications
    bio-rad.com
    Healthcare and Life Science 01 Sep 2026

    Bio-Rad expands Foresight Pro Prepacked Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing

    Extended Range of Process-Scale Columns Prepacked with CEX, AEX, CEX-HIC, and AEX-HIC Chromatography Resins Provides an Effective Solution for Purification of Biomolecules in Downstream Processing

    Zyme Communications
    Carterra logo
    Healthcare and Life Science 25 Aug 2026

    Carterra Enables Anthropic's Autonomous AI Protein Design Study via its HT-SPR Binding Platforms

    Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today highlighted the role of Carterra HT-SPR in one of the largest published wet-lab validations of AI-designed proteins to date.

    Zyme Communications
    Image: Dual binding Fab functioning as a conditional trans-activation logic gate for IL-12
    Healthcare and Life Science 20 Aug 2026

    FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation

    Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumor-conditional cytokine delivery FJBio engineered dual-specificity Fabs to meet model-defined affinity window through an end-to-end campaign across Porto and
    Zyme Communications
    The Qureight team at the new London office
    Healthcare and Life Science 19 Aug 2026

    Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

    Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financingSupports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design across broader range of chest dise
    Zyme Communications
    Dr Jack Kennefick,  CEO and Co-Founder,  Tagomics
    Healthcare and Life Science 17 Aug 2026

    Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

    Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of drug-safety across preclinical and clinical settings Early access programme now open for drug developers to shape future platform capabilities and applicationsNew bran
    Zyme Communications
    https://www.syngensys.com/
    Healthcare and Life Science 13 Aug 2026

    SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing

    ·       CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity

    Zyme Communications
    cn-bio.com
    Healthcare and Life Science 12 Aug 2026

    CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

    Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer
    Zyme Communications
    www.callali.ly/
    Healthcare and Life Science 11 Aug 2026

    Calla Lily Clinical Care selected to join Wellcome Leap’s $50M Focused Antibiotics Programme

    Callavid intravaginal drug delivery platform selected to advance targeted UTI treatment as part of new programme addressing antibiotic-driven antimicrobial resistance

    Zyme Communications
    Terry Pizzie, CEO, Broken String Biosciences
    Healthcare and Life Science 10 Aug 2026

    Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development

    •        Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows•        Researchers invited to gain early access to platform and support ongoing product development

    Zyme Communications
    DNA Script
    Healthcare and Life Science 04 Aug 2026

    DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction

    FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies

    Pagination

    • First page «
    • Previous page ‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • …
    • Next page ›
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS